XML 36 R25.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Compensatory Equity Incentive Plan and Other Equity Incentives (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Schedule of share based compensation award plans | These plans are summarized below:
|  |  |  |  |  | Award Shares |  |  | Available for |
|  |  |  |  |  | Outstanding |  |  | Issuance |
|  |  | Award |  |  | at March 31, |  |  | at March 31, |
| Equity Compensation Arrangement |  | Authorized |  |  | 2017 |  |  | 2017 |
| Amended and Restated Omnibus Incentive Plan |  |  | 3,915,625 |  |  |  | 2,602,968 |  |  |  | 633,701 |
| Employee Stock Purchase Plan |  |  | 400,000 |  |  |  | — |  |  |  | 377,988 |
|  |  |  | 4,315,625 |  |  |  | 2,602,968 |  |  |  | 1,011,689 |
Schedule of stock options fair value assumptions | For stock options granted in the nine month periods ended March 31, 2017 and 2016, we estimated the fair value of each stock option as of the date of grant using the following assumptions:
|  | Nine months |  |  | Nine months |
|  | March 31, 2017 |  |  | March 31, 2016 |
Weighted average expected volatility |  |  | 77% - 83% |  |  |  | 68% - 103% |
Dividend yields |  |  | 0% |  |  |  | 0% |
Weighted average risk-free interest rate |  |  | 1.18% - 1.90% |  |  |  | 0.37% - 1.49% |
Weighted average expected term, in years |  |  | 7.49 |  |  |  | 4.29 - 7.50 |
Schedule of share based compensation awards activity | A summary of the activity for share-based compensation awards in the nine months ended March 31, 2017 is presented below:
|  |  |  |  |  |  |  |  |  |  | Restricted |
|  | Stock Options |  |  | Stock Units (RSUs) |
|  |  |  |  |  |  | Weighted |  |  |  | Weighted |  |  |  |  |  |  |  | Weighted |
|  |  |  |  |  |  | Average |  |  |  | Average |  |  |  |  |  |  |  | Average |
|  |  |  |  |  |  | Exercise |  |  |  | Remaining |  |  |  |  |  |  |  | Remaining |
|  |  |  |  |  |  | Price |  |  |  | Contract |  |  |  |  |  |  |  | Contract |
|  |  | Shares |  |  |  | (per share) |  |  |  | Life (YRS) |  |  |  | Shares |  |  |  | Life (YRS) |
June 30, 2016 |  |  | 819,260 |  |  | $ | 1.90 |  |  |  | 5.6 |  |  |  | 1,311,795 |  |  |  | 0.9 |
Granted |  |  | 339,926 |  |  | $ | 1.61 |  |  |  | 9.6 |  |  |  | 230,772 |  |  |  | 2.6 |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (33,785 | ) |  |  | — |
Cancelled/Forfeited |  |  | (65,000 | ) |  | $ | 4.26 |  |  |  | — |  |  |  | — |  |  |  | — |
March 31, 2017 |  |  | 1,094,186 |  |  | $ | 1.67 |  |  |  | 6.6 |  |  |  | 1,508,782 |  |  |  | 1.0 |
Awards exercisable/vested as of |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
March 31, 2017 |  |  | 850,425 |  |  | $ | 1.70 |  |  |  | 5.9 |  |  |  | 1,069,870 |  |  |  | — |
Awards unexercisable/unvested as of |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
March 31, 2017 |  |  | 243,761 |  |  | $ | 1.56 |  |  |  | 8.8 |  |  |  | 438,912 |  |  |  | 1.0 |
|  |  | 1,094,186 |  |  |  |  |  |  |  |  |  |  |  | 1,508,782 |  |  |  |  |
|  |  | Stock Options |  |  | RSUs |  |  | All Awards |
Weighted average fair value of share awards granted in period |  |  | $ | 1.15 |  |  | $ | 1.56 |  |  | $ | 1.32 |
Schedule of share based compensation future cost to be recognized | We expect to recognize the compensation cost as follows:
|  |  | Stock |  |  |  |  |  |  |
|  |  | Options |  |  | RSUs |  |  | Total |
Three months ended June 30, 2017 |  |  |  | 12,597 |  |  |  | 63,735 |  |  |  | 76,332 |
Year ended June 30, 2018 |  |  |  | 39,612 |  |  |  | 244,917 |  |  |  | 284,529 |
Year ended June 30, 2019 |  |  |  | 17,784 |  |  |  | 144,984 |  |  |  | 162,768 |
Year ended June 30, 2020 |  |  |  | 3,243 |  |  |  | 29,989 |  |  |  | 33,232 |
Year ended June 30, 2021 |  |  |  | 242 |  |  |  | — |  |  |  | 242 |
|  |  | $ | 73,478 |  |  | $ | 483,625 |  |  | $ | 557,103 |
Summary of the number and weighted average grant date fair values regarding our unexercisable/unvested awards | The following table is a summary of the number and weighted average grant date fair values regarding our unexercisable/unvested awards as of March 31, 2017 and changes during the nine months then ended:
Unexercisable/unvested awards |  | Stock Options Shares |  |  | RSU Shares |  |  | Total Shares |  |  | Weighted-Average Grant Date Fair Values (per share) |
June 30, 2016 |  |  | 182,250 |  |  |  | 441,599 |  |  |  | 623,849 |  |  | $ | 1.35 |
Granted |  |  | 339,926 |  |  |  | 230,772 |  |  |  | 570,698 |  |  | $ | 1.32 |
Vested |  |  | (274,665 | ) |  |  | (233,459 | ) |  |  | (508,124 | ) |  | $ | 1.28 |
Cancelled/Forfeited |  |  | (3,750 | ) |  |  | — |  |  |  | (3,750 | ) |  | $ | 1.08 |
March 31, 2017 |  |  | 243,761 |  |  |  | 438,912 |  |  |  | 682,673 |  |  | $ | 1.38 |
Schedule of share based compensationincluded in the consolidated statements of comprehensive income | The following table shows total stock-based compensation expense for the nine months ended March 31, 2017 and 2016 included in the consolidated statements of comprehensive income:
|  | Nine months ended |  |  | Nine months ended |
|  | March 31, |  |  | March 31, |
|  | 2017 |  |  | 2016 |
Stock options |  | $ | 34,882 |  |  | $ | 37,125 |
RSUs |  |  | 284,300 |  |  |  | 224,490 |
Total |  | $ | 319,182 |  |  | $ | 261,615 |
The amounts above were included in: |  |  |  |  |  |  |  |
Selling, general & administrative |  | $ | 315,429 |  |  | $ | 260,450 |
Cost of sales |  |  | 2,792 |  |  |  | 238 |
New product development |  |  | 961 |  |  |  | 927 |
|  | $ | 319,182 |  |  | $ | 261,615 |

X
- Definition Tabular disclosure of the number of unvested share options and restricted stock units and shares expected to vest at the date of the latest statement of financial position, weighted-average exercise price (or conversion ratio), aggregate intrinsic value (except for nonpublic entities), and weighted-average remaining contractual term for both options and restricted stock units currently outstanding and options and restricted stock units exercisable (or convertible). + References No definition available. + Details
Name: | lpth_ShareBasedCompensationArrangementByShareBasedPaymentAwardsUnvestOutstandingAndExercisableTableTextBlock
Namespace Prefix: | lpth_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 + Details
Name: | us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of share-based compensation plans that may be presented in a single table for outstanding, vested and expected to vest, and exercisable awards. The information that may be disclosed in this table may include, but is not limited to, number of shares, weighted average exercise price, weighted average remaining contractual life, and aggregate intrinsic value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the total compensation cost related to nonvested awards not yet recognized and the weighted-average period over which it is expected to be recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration